Bulletin
Investor Alert

Market Pulse Archives

June 2, 2021, 8:49 a.m. EDT

U.S. to run 'mix-and-match' clinical trial testing Moderna's vaccine as booster shot

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Pfizer Inc. (PFE)
  • X
    Moderna Inc. (MRNA)
  • X
    Johnson & Johnson (JNJ)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

The National Institutes of Health said Tuesday it plans to test booster shots from different vaccines in a fully vaccinated population as part of a "mix-and-match" clinical trial. The Phase 1/2 study is being funded by the National Institute of Allergy and Infectious Diseases. It will enroll 150 participants who have received either the two-dose, mRNA-based shots developed by Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.63% /BioNTech SE [b: bntx] and Moderna Inc. /zigman2/quotes/205619834/composite MRNA +2.53% or Johnson & Johnson's /zigman2/quotes/201724570/composite JNJ +0.44% single shot. The participants will then receive a booster shot of Moderna's vaccine 12 to 20 weeks after finishing their initial vaccine regimen. "We need to prepare for the possibility of needing booster shots to counter waning immunity and to keep pace with an evolving virus," NIAID Director Dr. Anthony Fauci said in a news release. Both Pfizer and Moderna are already running their own clinical trials for different types of booster shots.

/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 43.92
-0.28 -0.63%
Volume: 23.63M
Sept. 21, 2021 4:02p
P/E Ratio
18.81
Dividend Yield
3.55%
Market Cap
$247.82 billion
Rev. per Employee
$580,595
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 434.04
+10.71 +2.53%
Volume: 9.34M
Sept. 21, 2021 4:00p
P/E Ratio
54.18
Dividend Yield
N/A
Market Cap
$170.88 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 164.53
+0.72 +0.44%
Volume: 6.66M
Sept. 21, 2021 4:00p
P/E Ratio
24.74
Dividend Yield
2.58%
Market Cap
$431.23 billion
Rev. per Employee
$613,918
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.